Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

NCT00367718 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI left JHU and is not able to be reached for updates

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Velcade

Sponsor

Johns Hopkins University

Collaborators

[object Object]